Key result
MYPT1 glutamic acids within the leucine repeat region enhance binding affinity with MRIP.
Why the study?
The biophysical properties and molecular determinants of the interaction between MYPT1 and MRIP scaffold proteins were not fully characterized.
Glutamic acids 998-1000 within the leucine repeat region of MYPT1 play an important role in its interaction with MRIP.
Answers are grounded in this paper and cite their sources.
No clinical implications yet; leaves open the functional impact of these residues on myosin phosphatase activity in vivo.
Scaffold proteins bind to and functionally link protein members of signaling pathways. Interaction of the scaffold proteins, myosin phosphatase target subunit (MYPT1) and myosin phosphatase-RhoA interacting protein (MRIP), causes co-localization of myosin phosphatase and RhoA to actomyosin. To examine biophysical properties of interaction of MYPT1 with MRIP, we employed analytical ultracentrifugation and surface plasmon resonance. In regard to MRIP, its residues 724-837 are sufficient for the MYPT1/MRIP interaction. Moreover, MRIP binds to MYPT1 as either a monomer or a dimer. With respect to MYPT1, its leucine repeat region, LR (residues 991-1030) is sufficient to account for the MYPT1/MRIP interaction. Furthermore, point mutations that replace glutamic acids 998-1000 within LR reduced the binding affinity toward MRIP. This suggests that the glutamic acids of MYPT1 play an important role in the interaction.
No takes yet. Share an insight, caveat, or question.
Lee et al. (2015) studied this question. MYPT1 and MRIP peptides was evaluated on Protein-protein interaction and binding affinity. The leucine repeat region of MYPT1 and residues 724-837 of MRIP are sufficient for their interaction, and glutamic acids 998-1000 within MYPT1 enhance this binding affinity.
Synapse has enriched 10 related papers. Consider them for comparative context: